Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Leif William Ellisen, M.D.,Ph.D.

Concepts (514)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Leif Ellisen's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Leif Ellisen has written about over time.
DNA-Binding Proteins, 19 publications between 1997 and 2016, average publication date May 2006. Nuclear Proteins, 12 publications between 2001 and 2011, average publication date March 2008. Trans-Activators, 13 publications between 2001 and 2014, average publication date March 2008. Transcription Factors, 29 publications between 1991 and 2020, average publication date June 2008. Tumor Suppressor Proteins, 23 publications between 1998 and 2016, average publication date July 2008. Phosphoproteins, 10 publications between 2002 and 2016, average publication date November 2009. Cisplatin, 7 publications between 2007 and 2015, average publication date August 2010. Carcinoma, Squamous Cell, 14 publications between 2006 and 2018, average publication date February 2012. Tumor Suppressor Protein p53, 12 publications between 2002 and 2022, average publication date April 2013. BRCA2 Protein, 8 publications between 1998 and 2020, average publication date February 2014. ras Proteins, 4 publications between 2010 and 2020, average publication date June 2014. Head and Neck Neoplasms, 6 publications between 2006 and 2021, average publication date September 2014. BRCA1 Protein, 11 publications between 1999 and 2024, average publication date May 2015. Breast Neoplasms, 35 publications between 1998 and 2023, average publication date August 2015. Genes, Neoplasm, 3 publications between 2014 and 2017, average publication date October 2015. High-Throughput Nucleotide Sequencing, 7 publications between 2012 and 2020, average publication date February 2016. Drug Resistance, Neoplasm, 8 publications between 2007 and 2023, average publication date June 2016. Immunoconjugates, 3 publications between 2020 and 2023, average publication date November 2021. Camptothecin, 2 publications between 2021 and 2023, average publication date October 2022.

To see the data from this visualization as text, click here.
Ellisen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (514)
Explore
_
Co-Authors (178)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.